The health and wellness trend has become a powerful catalyst for growth in NRT smoking cessation aids in India. It has heightened awareness of the numerous health risks associated with smoking, including lung cancer, cardiovascular diseases, and respiratory ailments. As a result, many smokers are actively seeking ways to quit and improve their overall health. Nicotine replacement products such as nicotine gum (which is dominant), patches, and lozenges, have gained popularity because they offer a...
Euromonitor International's NRT Smoking Cessation Aids in India report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2018-2022, allowing you to identify the sectors driving growth. Forecasts to 2027 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report? * Get a detailed picture of the NRT Smoking Cessation Aids market; * Pinpoint growth sectors and identify factors driving change; * Understand the competitive environment, the market’s major players and leading brands; * Use five-year forecasts to assess how the market is predicted to develop.
NRT Smoking Cessation Aids in India
Euromonitor International
November 2023
List Of Contents And Tables
NRT SMOKING CESSATION AIDS IN INDIA
KEY DATA FINDINGS
2023 DEVELOPMENTS
Increasing health awareness dictates the growth of the category
Cipla remains the dominant player thanks to its trusted name and wide resources